Clinical Trials Browser

Phase 2 × pyrotinib × Genitourinary × Clear all

NCT05318339 2022-04-08

A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell